Chain of events at Abbott ‘s Diagnostic Work Shop

1.Investors pleased with diagnostic gains.
2.Promising companion diagnostic deal with Idera.
3. Slashing jobs in one of DX division.
4. Remarkable Q2 for Diagnostic segment
5.Launch of cheaper and quicker infection prevention diagnostic platforms.
6. IRIDICA snagging CE mark.

Time for Abbott’s diagnostics wing seems to be just perfect. Investors pleased with gains , promising companion diagnostic deal with Idera , all adding up to company’s growth and glory in diagnostics. There were certain hiccups here and there , which involved slashing of jobs in certain operational units manufacturing diagnostic tools. However gains outrun the losses or fallbacks , where company had a lot to brag  around Q2 gains , cheaper and quicker platform launches ( IRIDICA) and others.
Overall Abbott is on winning streak in Diagnostic space. Hope to add more of accomplishments and less of fall backs for the company in coming days.

Medical Device Trends
http://www.medicaldevicetrend.com

Published by PharMed Intel

Pharmed Intel is your single source of all major updates in Pharma and medical device industry. If you want to capture insights on what is creating a buzz in your pharma or medical device subcategory, this is a portal you need to be at. What are Top API CMOs, Formulation CMOs, Medical CMOs or CROs doing? Is a question that all Pharma and medtech buyers are interested to get insights on, this portal gives you that update on the go. Follow us on twitter : PHARMED INTEL @PHARMED_INTEL View all posts by PharMed Intel